SyncroPatch 384, 
Patchliner, 
Port-a-Patch Webinar
Date: September 07. 2021, 4:00 PM CEST (10:00 AM EDT)
Abstract:
Calcium (Ca2+) is a universal signalling molecule and is critically important in regulating many physiological functions and survival of RBCs. Amongst others, intracellular Ca2+ controls cell volume and deformability. This process plays a substantial role in RBCs since their volume needs to adapt when passing blood vessel constrictions during the flow. Excessive Ca2+ uptake also leads to accelerated cell clearance causing anaemia.
Therefore, studying Ca2+ regulation is crucial to understand RBC diseases. Piezo1, KCa3.1 (Gardos channel) and NMDA receptors are three channels present in the RBC membrane and critical for Ca2+ regulation.
We developed functional assays to measure these channels in healthy and diseased RBCs populations using electrophysiological tools, contributing to the characterization of RBC diseases.
SyncroPatch 384i
Date: March 11. 2021
Speakers:
Ciria Hernandez, MD, Ph.D
(Assistant Research Scientist - University of Michigan Life Sciences Institute)
Yuri Kuryshev
(Principal Scientist - Charles River Laboratories)
SyncroPatch 384i and Patchliner Webinar
Date: October 14. 2020
Speakers:
Dr. Marc Rogers (Metrion Biosciences; U.K.)
This is an on-demand webinar from Nan]i[on and Friends 2020.
SyncroPatch 384i Webinar
Date: October 15. 2020
Speakers:
Dr. Oliver Wehmeier (acCELLerate GmbH) and Dr. Tim Strassmaier (Nanion Technologies)
This is an on-demand webinar from Nan]i[on and Friends 2020.
Patchliner and SyncroPatch 384i Webinar
Date: October 15. 2020
Speakers:
Dr. Sonja Stoelzle-Feix (Nanion Technologies)
This is an on-demand webinar from Nan]i[on and Friends 2020.
Patchliner and SyncroPatch 384i Webinar
Date: October 15. 2020
Speakers:
Dr. Alison Obergrussberger (Nanion Technologies)
This is an on-demand webinar from Nan]i[on and Friends 2020.
SyncroPatch 384i Webinar
Date: October 16. 2020
Speakers:
Dr. Torsten Fauth (BRAIN AG)
Dr. Oliver Rauh (Technical University of Darmstadt)
Giustina Rotordam (Nanion Technologies)
This is an on-demand webinar from Nan]i[on and Friends 2020.
SyncroPatch 384i Webinar
Date: October 12. 2020, 2:00 PM CET (8:00 AM EDT)
Speakers:
Prof. Dr. med. Angelika Lampert (RWTH Aachen University, Institute of Physiology (Neurophysiology))
This is an on-demand webinar from Nan]i[on and Friends 2020.
SyncroPatch 384i Webinar
Date: October 12. 2020, 4:00 PM CET (10:00 AM EDT)
Speakers:
Fernanda Laezza, M.D. Ph.D. | Graduate Program Director & Associate Professor (Department of Pharmacology & Toxicology University of Texas Medical Branch)
This is an on-demand webinar from Nan]i[on and Friends 2020.
SyncroPatch 384i Webinar
Date: October 12. 2020, 5:00 PM CET (11:00 AM EDT)
Speakers:
Lei A. Wang | Research Scientist (Stanley Center for Psychiatric Research - Broad Institute of MIT and Harvard)
This is an on-demand webinar from Nan]i[on and Friends 2020.
SyncroPatch 384i Webinar
Date: June 4. 2020, 4:00 PM CET (10:00 AM EDT)
Speakers:
Rodolfo Haedo (COO; Nanion Technologies North America)
Dr. Jen Q. Pan (Director, Translational Neurobiology; Broad Institute of MIT and Harvard)
Prof. Al George (Magerstadt Professor and Chair - Department of Pharmacology; Northwestern University - Feiberg School of Medicine)
SyncroPatch 384PE (a predecessor model of SyncroPatch 384i), Patchliner, Port-a-Patch Webinar
Date: November 20. 2018, 4:00 PM CET (11:00 AM EDT)
The Webinar focuses on the automated patch clamp assay development for the study of red blood cells in health and disease and the RELEVANCE project, an international consortium of 13 partners from academia, diagnostic labs, blood supply centers, and small companies that combines basic and translational research to improve prognostic, diagnostic and therapeutic approaches on red blood cell function in health and disease. To this end, Nanion contributes assays for the electrophysiological characterization of healthy and patient-derived red blood cells.
CardioExcyte 96, Patchliner and SyncroPatch 384PE (a predecessor model of SyncroPatch 384i) Webinar
Date: September 12, 4:00 PM CEST (10:00 AM EDT)
Get up-to-date with the CiPA progress of the Myocyte and Ion Channel Work Goups:
- CiPA myocyte phase II validation study results: cross-site comparison using the CardioExcyte 96
- HTS Phase I study: an update on progress of the CiPA Ion Channel Work Stream using the SyncroPatch 384PE and Patchliner
SyncroPatch 384PE (a predecessor model of SyncroPatch 384i)
Learn about Sodium Ion Channel Assays on the SyncroPatch 384PE. Our speakers will present assays on NaV1.1, NaV1.7, NaV1.8 and NaV1.9:
- Biophysical and Pharmacological Characterization of Voltage-Gated Na Channels Involved in Pain Pathways.
- Identifying NaV1.1 Enhancers to Restore Inhibitory Interneuron Function in Dravet Syndrome and Alzheimer’s Disease.
SyncroPatch 384PE (a predecessor model of SyncroPatch 384i)
This webinar will show high-throughput functional annotation of human ion channel variants associated with excitation disorders will be described along with use of the Syncropatch 384PE to measure subtype selective activation of KV7 potassium channels as well as inhibition of voltage gated sodium channels like NaV1.7, NaV1.1, and NaV1.5.
Organisation: Icagen Inc.
SyncroPatch 384PE (a predecessor model of SyncroPatch 384i)
AstraZeneca has implemented the Nanion SyncroPatch 384PE electrophysiology platform. This webinar will show how AstraZeneca and Genedata developed a processing and analysis pipeline for the complex data, reading binary raw data directly from the instrument into Genedata Screener.
Organisation: Genedata AG.
SyncroPatch 384PE (a predecessor model of SyncroPatch 384i) and Patchliner
The webinar covers the use of the Patchliner and the SyncroPatch 384/768PE for characterization of ion channels and screening of ion channel active compounds.
SyncroPatch 384PE (a predecessor model of SyncroPatch 384i)
The Webinar covers the introduction of the SyncroPatch 384PE and its features.
SyncroPatch 96 (a predecessor model of SyncroPatch 384PE)
This Webinar covers the general setup of the and features of this automated patch clamp device.
FLEXcyte 96 Webinar
Orbit mini Webinar
Orbit 16
This webinar covers the use of the lipid bilayer platforms from Nanion: the Orbit16 and the Orbit mini for characterization of membrane proteins like ion channels, bacterial porins and biological nanopores. Both bilayer systems support high quality low noise recordings, but differ in throughput capabilities and experimental features. The Orbit16, introduced in 2012 is a device for efficient formation of 16 lipid bilayers simultaneously, allowing for parallel bilayer-reconstitution of ion channels and nanopores.
SURFE2R N1
SURFE²R 96SE and